Literature DB >> 16572307

Treatment of SVC syndrome and hemoptysis in a patient with mediastinal fibrosis.

Bradley P Thomas1, Peter R Bream, Aaron P Milstone, Steven G Meranze.   

Abstract

Mediastinal fibrosis can present with a multitude of symptoms, most commonly cough, dyspnea and hemoptysis. We describe a case of mediastinal fibrosis secondary to histoplasmosis, which presented with both superior vena cava syndrome (SVCS) and hemoptysis. Our patient was successfully treated with bronchial artery embolization followed by SVC stent placement during a brief hospital stay.

Entities:  

Mesh：

Year:  2006        PMID： 16572307     DOI： 10.1007/s10140-005-0442-z

Source DB:  PubMed          Journal:  Emerg Radiol        ISSN： 1070-3004


  7 in total

Review 1.  Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review.

Authors:  Woong Yoon; Jae Kyu Kim; Yun Hyun Kim; Tae Woong Chung; Heoung Keun Kang
Journal:  Radiographics       Date:  2002 Nov-Dec       Impact factor: 5.333

Review 2.  Mediastinal fibrosis complicating histoplasmosis.

Authors:  J E Loyd; B F Tillman; J B Atkinson; R M Des Prez
Journal:  Medicine (Baltimore)       Date:  1988-09       Impact factor: 1.889

3.  The radiographic findings of fibrosing mediastinitis.

Authors:  A D Sherrick; L R Brown; G F Harms; J L Myers
Journal:  Chest       Date:  1994-08       Impact factor: 9.410

4.  Bronchial and nonbronchial systemic arteries at multi-detector row CT angiography: comparison with conventional angiography.

Authors:  Martine Remy-Jardin; Nebil Bouaziz; Philippe Dumont; Pierre-Yves Brillet; John Bruzzi; Jacques Remy
Journal:  Radiology       Date:  2004-10-14       Impact factor: 11.105

5.  Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer.

Authors:  A Urruticoechea; R Mesía; J Domínguez; C Falo; E Escalante; A Montes; C Sancho; F Cardenal; M Majem; J R Germà
Journal:  Lung Cancer       Date:  2004-02       Impact factor: 5.705

6.  Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease.

Authors:  Manju Kalra; Peter Gloviczki; James C Andrews; Kenneth J Cherry; Thomas C Bower; Jean M Panneton; Haraldur Bjarnason; Audra A Noel; Cathy Schleck; William S Harmsen; Linda G Canton; Peter C Pairolero
Journal:  J Vasc Surg       Date:  2003-08       Impact factor: 4.268

7.  Endovascular treatment of stenoses in the superior vena cava syndrome caused by non-tumoral lesions.

Authors:  A Bornak; S Wicky; H-B Ris; H Probst; I Milesi; J-M Corpataux
Journal:  Eur Radiol       Date:  2002-09-18       Impact factor: 5.315
  7 in total
  3 in total

1.  Fibrosing Mediastinitis: Uncommon Life-threatening Complication of Histoplasmosis.

Authors:  Muhammad Khalid; Imran Khan; Zia Rahman; Ahmad Alazzeh; Dima Youssef
Journal:  Cureus       Date:  2018-04-25

2.  Endovascular Treatment of Bilateral Pulmonary Artery Stenoses and Superior Vena Cava Syndrome in a Patient with Advanced Mediastinal Fibrosis.

Authors:  Leonardo I Valentin; Joshua D Kuban; Rohit Ramanathan; Cliff J Whigham
Journal:  Tex Heart Inst J       Date:  2016-06-01

3.  Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis.

Authors:  Erin L Albers; Meredith E Pugh; Kevin D Hill; Li Wang; James E Loyd; Thomas P Doyle
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.